Gajanan Sonawane

Gajanan Sonawane

Auto-generated profile, based on publicly available information

Gajanan Sonawane

Department of Biotechnology (With Jointly Merged Institute of Bioinformatics and Biotechnology) , Savitribai Phule Pune University , Ganeshkhind, Pune , 411007 , Maharashtra , India , unipune.ac.in

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in IET Nanobiotechnology
Verified
Journal Article
Open access
PDF file
NSNeha Saini
Neha Saini
GSGajanan Sonawane
Gajanan Sonawane
KYKyunghee Yun
Kyunghee Yun
HHHyeshin Hwang
Hyeshin Hwang
KKKyungmin Kim
Kyungmin Kim
AKAtul Kulkarni
Atul Kulkarni
The heterogeneity of glioblastoma and recurrence pose a major threat to the life of brain cancer patients. The failure of the current therapeutic regime in preventing its recurrence leads to a growing need for effective cancer treatments with lesser side effects. Previous studies have shown the potential of plants extract to synthesize silver nanoparticles (AgNPs) against U‐87 MG cell line. However, the need for optimum sized and effective nanoparticles is still not fulfilled. Hence, the current work aimed to utilize size controlled bioavailable AgNPs capped with Aloe barbadensis (aqueous extracts) and study their effectiveness against U‐87 MG cells. Two different concentrations of Aloe vera extract (ALE) viz. ALE1 and ALE2, were used. Their physiochemistry was characterized via UV–Vis, dynamic light scattering (DLS), FE‐SEM (50–60 nm diameter), and energy dispersive X‐ray (EDX). The observed zeta potentials were −8 and −16 mV for ALE1– and ALE2–AgNPs, respectively. This indicated that ALE2–AgNPs were more stable. Further, the anticancer potency of both ALE–AgNPs at 0, 24, and 48 h was evaluated. MTT‐assay revealed ALE2–AgNPs were more cytotoxic, significantly inhibiting the proliferation of U‐87 MG, indicating their dose‐dependent cytotoxicity. At an effective concentration of ALE2–AgNPs, (i.e., 10 µg/mL) viability of cancer cell line decreased significantly to 40% after 24 h of treatment. In apoptotic analysis pronounced elevation in early apoptotic cells was noted (5.1% and 9.9% for ALE1– and ALE2–AgNPs, respectively). The significant cytotoxicity and observed apoptosis induction shows ALE–AgNPs’s therapeutic potential against glioblastoma and aqueous extract shows its high biocompatibility, thus having significant probability to be translated in clinical settings.